The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL pro In Vitro
Article
[키워드] 3CL pro
3CLpro
Amino acid
antiparasitic
approved
AstraZeneca
binding
clinically
Combination
confirmed case
COVID-19
COVID-19 disease
COVID-19 vaccines
demonstrated
described
disease
docking
drug
drug candidate
drug combination
drugs
effective
Efficacy
eight
Emergency use
experiment
identify
inhibit SARS-CoV-2
inhibitory
Interaction
interactions
involved
Johnson & Johnson
magnitude
main protease
moderate
Moderna
molecular
offer
pandemic
Pfizer-BioNTech
Pneumonia
quinacrine
reported
Repurposing approved drugs
resulting
Safe
SARS-CoV-2
SARS-CoV-2 infections
SARS-CoV-2 main protease
SARS-CoV-2 protein
SPR
Spread
suggested
Suramin
surface plasmon resonance
synergistic
the WHO
therapeutic
treat
Treatment
Vaccine
variant
Wuhan, China
[DOI] 10.3390/v13050873 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v13050873 PMC 바로가기 [Article Type] Article